Servier Canada Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Servier Canada Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013344
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Servier Canada Inc (SCI), a subsidiary of Les Laboratoires Servier SAS is a manufacturer and distributor of generic and ethical products. The company’s products include perindopril erbumine tablets, perindopril erbumine indaparride tablets, glidazide modified release tablets, glidazide tablets, indapamide and perindopril arginine amodipine tablets. It also provides clinical research and large-scale clinical trials required for drug development. The company markets its products in Vietnam, Venezuela, the UK, Lithuania, Japan, Ireland, Indonesia, India, Hungary, Greece, Germany, France, Finland, Denmark, Czech Republic, China, Canada, Bulgaria, Brazil, Belarus, Austria and Australia. It operates through its offices in Laval and Mississauga, Canada. SCI is headquartered in Laval, Quebec, Canada.

Servier Canada Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Servier Canada Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Servier Canada Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Servier Canada Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Servier Canada Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Servier Canada Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Servier Canada Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ilkos Therapeutics Raises USD14 Million in Seed Financing 10
Partnerships 11
Daiichi Sankyo Enters into Distribution Agreement with Servier Canada 11
Spectrum Pharma Enters into Agreement with Servier Canada 12
Licensing Agreements 13
Ilkos Therapeutics Enters into Licensing Agreement with Servier Canada 13
Servier Canada Inc – Key Competitors 14
Servier Canada Inc – Key Employees 15
Servier Canada Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Product News 17
Nov 10, 2017: Servier Canada announces the launch of VENIXXA, an over-the-counter oral treatment to relieve signs and symptoms of chronic venous disease and hemorrhoids 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Servier Canada Inc, Pharmaceuticals & Healthcare, Key Facts 2
Servier Canada Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Servier Canada Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Servier Canada Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Servier Canada Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Servier Canada Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ilkos Therapeutics Raises USD14 Million in Seed Financing 10
Daiichi Sankyo Enters into Distribution Agreement with Servier Canada 11
Spectrum Pharma Enters into Agreement with Servier Canada 12
Ilkos Therapeutics Enters into Licensing Agreement with Servier Canada 13
Servier Canada Inc, Key Competitors 14
Servier Canada Inc, Key Employees 15
Servier Canada Inc, Other Locations 16

★海外企業調査レポート[Servier Canada Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Moog Inc (MOG.A):企業の財務・戦略的SWOT分析
    Moog Inc (MOG.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Juniper Pharmaceuticals Inc (JNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company uti …
  • Heliatek GmbH-エネルギー分野:企業M&A・提携分析
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Kenya Electricity Generating Co Ltd (KGEN):電力:M&Aディール及び事業提携情報
    Summary Kenya Electricity Generating Co Ltd (KenGen) is an electricity generation utility. It produces power from hydro, geothermal, thermal, and wind sources. Under power purchase agreements, the company sells power to customers on wholesale basis. Kenya Power and Lighting Company Limited is the au …
  • Commerzbank AG:戦略・SWOT・企業財務分析
    Commerzbank AG - Strategy, SWOT and Corporate Finance Report Summary Commerzbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Offshore Marine Management Limited:企業の戦略的SWOT分析
    Offshore Marine Management Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Itochu Chemical Frontier Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company’s business division includes intermediate chemical division, performance product division, eco chemical and l …
  • Lohmann & Rauscher GmbH & Co. KG:企業の戦略的SWOT分析
    Lohmann & Rauscher GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Fujikura Ltd.:企業の戦略・SWOT・財務分析
    Fujikura Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fujikura Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Alphatec Holdings Inc (ATEC):医療機器:M&Aディール及び事業提携情報
    Summary Alphatec Holdings Inc (Alphatec) is a medical technology company that focuses on the design, development and marketing of spinal fusion technology products and solutions for the treatment of spine disorders. The company’s major products include anterior cervical plate system, posterior cervi …
  • Toshiba Corporation:企業のM&A・事業提携・投資動向
    Toshiba Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Toshiba Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Mutual Trust Bank Limited:企業の戦略・SWOT・財務情報
    Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data a …
  • Petroleo Brasileiro SA:企業の戦略・SWOT・財務情報
    Petroleo Brasileiro SA - Strategy, SWOT and Corporate Finance Report Summary Petroleo Brasileiro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Misonix Inc (MSON):企業の財務・戦略的SWOT分析
    Misonix Inc (MSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Luye Pharma Group Co Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • Range Resources Corp (RRC):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …
  • AcuFocus Inc-医療機器分野:企業M&A・提携分析
    Summary AcuFocus Inc (AcuFocus) is a medical device company that develops and markets technologies for the improvement of near vision. The company's products include kamra inlay, small aperture lens and acutarget HD instrument. It offers near vision solutions and develops ophthalmic medical devices. …
  • Toyota Industries Corporation:企業の戦略・SWOT・財務情報
    Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆